V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough

Enzo Biochem Executive Compensation (FY24)

ENZ · Executive and director compensation, fiscal 2023 to 2024
Chief executive, fiscal 2024
◇
Kara Cannon
Latest say-on-pay support
=
January 15, 2025
Velarion Member: every covered company in one industry, with dashboards, peer screens and board-ready briefs. Three seats, one year.
Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.

The paid brief on Enzo Biochem

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$1,500 for the Executive Compensation Report. Both reports for $2,400.
Get the executive briefGet the board briefNo account needed.
Data as of October 22, 2026Latest filing (8-K): January 16, 2025
9 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Enzo Biochem brief$1,500Get the executive brief
Velarion Member, one year
111 figures on this page: 103 cited to the filing that reported them, 8 calculated from figures it prints. See the citations

More on Enzo Biochem

Five data products on this company. Each one is requested through the developer setup page.
What changed from fiscal 2023 to fiscal 2024
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Kara Cannon: $1,371,793 → $999,352 (27.1% lower)
Say-on-pay support: 44.6% → 76.2% (31.6 points higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is Enzo Biochem's chief executive and what were they paid?
Kara Cannon was paid $999,352 in total compensation as Chief Executive Officer for fiscal 2024. Compared with the $1,371,793 reported for fiscal 2023, Cannon's total was 27.1% lower.
What was Enzo Biochem's say-on-pay result?
Shareholders supported the say-on-pay proposal with 76.2% of votes cast for or against in favor at the meeting held January 15, 2025 for fiscal 2024.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Hamid Erfanian
Former Chief Executive Officer
◇◇◇◇——◇◇
Kara Cannon
Chief Executive Officer
◇◇◇◇◇—◇◇
Patricia Eckert
Chief Financial Officer
◇◇—◇◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Kara Cannon
Chief Executive Officer
◇—◇◇◇—◇◇
Hamid Erfanian
Former Chief Executive Officer
Departed during or after this year
◇◇————◇◇
Patricia Eckert
Chief Financial Officer
◇——◇◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2024
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Kara CannonOption——————◇
Kara CannonPSU——————◇
Patricia EckertOption——————◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2024 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Patricia EckertOption◇—◇—
Option◇—◇—
Option◇—◇—
Option◇—◇—
Option◇—◇—
Kara CannonRSU◇◇——
Option◇—◇—
Option◇—◇—
Option◇—◇—
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
Patricia Eckert
Chief Financial Officer · Employment agreement
Severance multiple◇

Director compensation

What each non-employee director was paid.
Fiscal 2024
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Bradley L. Radoff
◇◇————◇
Steven J. Pully
Board chair
◇◇————◇
Mary Tagliaferri
◇—————◇
Ian B. Walters
◇—————◇
Elazar Rabbani
◇—————◇
Kara Cannon and Jon Couchman served on the board in fiscal 2024 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Lead independent director premium◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance chair◇
Nominating and governance member◇

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2024January 15, 2025=◇◇◇
2023January 31, 2024=◇◇◇
2020January 4, 2021=◇◇◇
2019February 25, 2020=◇◇◇
2018January 3, 2019=◇◇◇
2017January 5, 2018=◇◇◇
2016January 5, 2017=◇◇◇
2015January 6, 2016=◇◇◇

Velarion Pro: every company page, peer tools and exports, one seat

One seat, one person. It opens the whole platform: the peer tools, the written analysis and the exports, on every company we cover. Join the list and you will hear from us when it opens.
Your address is used for this and nothing else, and you can unsubscribe in one click. See the privacy policy.

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Kara Cannon (Chief Executive Officer), FY2024 total compensation $999,352 (base salary $376,423) [exec_comp, SEC accession 0001213900-24-103467, filed 2024-11-27]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

Tell me when Enzo Biochem files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Enzo Biochem disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether Enzo Biochem's disclosed peer group is defensible, who names Enzo Biochem back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
111 figures on this page: 103 cited to the filing that reported them, 8 calculated from figures it prints.
103 cited to the filing
8 calculated from the filing

Documents cited

  1. 0001213900-25-004240
    Item 5.07. Submission of Matters to a Vote of Security Holders.
  2. 0001213900-24-103467
    COMPENSATION OF DIRECTORS &
  3. 0001213900-24-008745
    Item 5.07. Submission of Matters to a Vote of Security Holders.
  4. 0001213900-21-001215
    Item 5.07 Submission of Matters to a Vote of Security Holders
  5. 0000930413-20-000690
    Item 5.07. Submission of Matters to a Vote of Security Holders.
  6. 0000930413-19-000010
    Item 5.07 Submission of Matters to a Vote of Security Holders
  7. 0000930413-18-000054
    Item 5.07 Submission of Matters to a Vote of Security Holders
  8. 0000930413-17-000087
    Item 5.07 Submission of Matters to a Vote of Security Holders
  9. 0000930413-16-004921
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Enzo Biochem executive compensation, FY2023–FY2024.” https://intel.velarion.ai/comp/ENZ (accessed 2026).
Short form: data: Velarion

The paid brief for Enzo Biochem

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$1,500 for the Executive Compensation Report. Both reports for $2,400.
Get the executive briefGet the board briefNo account needed.
9 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Enzo Biochem and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy